Inflammation and dyslipidemia related to risk of spontaneous preterm birth

American Journal of Epidemiology

Volumn 166, Issue 11, 2007, Pages 1312-1319

  Catov, Janet M ^a,b,c   Bodnar, Lisa M ^a,b,c   Ness, Roberta B ^a,b,c   Barron, Stacy J ^d   Roberts, James M ^a,b,c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

C reactive protein; Cardiovascular diseases; Cholesterol; Dyslipidemias; Inflammation; Premature birth; Triglycerides; Women

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; HEALTH RISK; IMMUNE RESPONSE; LIPID; METABOLISM; PARTURITION; PREGNANCY; PROTEIN; REGRESSION ANALYSIS;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; INFLAMMATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DYSLIPIDEMIAS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; PENNSYLVANIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 36248980350     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm273     Document Type: Article

References (35)

1. Smith G, Pell J, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6.
2. Davey Smith G, Sterne J, Tynelius P, et al. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology 2005;16:563-9.
3. Davey Smith G, Harding S, Rosato M. Relation between infants' birth weight and mothers' mortality: prospective observational study. BMJ 2000;320:839-40.
4. Irgens H, Reisaeter L, Irgens L, et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort. BMJ 2001;323:1213-17.
5. Sattar I, Greer I. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157-60.
6. Loukovaara M, Alfthan H, Kurki M, et al. Serum highly sensitive C-reactive protein in preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2003;110:26-8.
7. Goldenberg R, Hauth J, Andrews W. Mechanisms of disease: intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-7.
8. Hvilsom G, Thorsen P, Jeune B, et al. C-reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand 2002;81:424-9.
9. Pitiphat W, Gillman MW, Joshipura KJ, et al. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162:1108-13.
10. Catov JM, Newman AB, Roberts JM, et al. Association between infant birth weight and maternal cardiovascular risk factors in the Health, Aging, and Body Composition Study. Ann Epidemiol 2007;17:36-43.
11. Carey J, Klebanoff M, Hauth J, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-40.
12. Institute of Medicine. Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press, 2006.
13. Catov JM, Bodnar L, Kip K, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol (in press).
14. Bek K, Nielson F, Qvist I. C-reactive protein (CRP) and pregnancy. An early indicator of chorioamnionitis. A review. Eur J Obstet Gynecol Reprod Biol 1990;35:29-33.
15. National Cholesterol Education Program. Third report of the National Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). Bethesda, MD: National Heart Lung and Blood Institute, 2002.
16. Carpenter M, Coustan D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.
17. Witte J, Greenland S. A nested approach to evaluating doseresponse and trend. Ann Epidemiol 1997;7:188-93.
18. Wolf M, Kettyle E, Sandler L, et al. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98:757-62.
19. Qiu C, Luthy DA, Zhang C, et al. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004;17:154-60.
20. Khovidhunkit W, Kim M, Memon R, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169-96.
21. Engstrom G, Hedblad B, Janzon L, et al. Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: a longitudinal study. Am J Epidemiol 2006;17:57-63.
22. Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001;286:64-70.
23. Ridker PM, Rifai N, Pfeffer MA, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999;100:230-5.
24. Weinbrenner T, Schroder H, Escurriol V, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr 2006;83:30-5.
25. Van Guilder GP, Hoetzer GL, Greiner JJ, et al. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) 2006;14:2127-31.
26. Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-71.
27. Smith GCS, Shah I, Pell JP, et al. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health 2007;97:157-62.
28. Hendler I, Goldenberg RL, Mercer BM, et al. The Preterm Prediction study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol 2005;192:882-6.
29. Nohr EA, Bech BH, Vaeth M, et al. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2007;21:5-14.
30. Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231-7.
31. Stewart F, Freeman D, Ramsay JE, et al. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007;92:969-75.
32. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004;19:1644-6.
33. Wang X, Zuckerman B, Coffman G, et al. Familial aggregation of low birth weight among whites and blacks in the United States. N Engl J Med 1995;333:1744-9.
34. Simhan H, Krohn M, Roberts J, et al. Interleukin-6 promoter-174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 2003;189:915-18.
35. Engel SA, Erichsen HC, Savitz DA, et al. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005;16:469-77.